Sequential Therapy With Recombinant Human IGF ‐1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo‐Controlled Trial-Reference-Cited by-同舟云学术

Sequential Therapy With Recombinant Human IGF ‐1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo‐Controlled Trial

Published:2021-09-02 Issue:11 Volume:36 Page:2116-2126
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Haines Melanie Schorr¹²^ORCID,Kimball Allison¹²,Meenaghan Erinne¹,Bachmann Katherine N¹²,Santoso Kate¹,Eddy Kamryn T²³,Singhal Vibha¹²^ORCID,Ebrahimi Seda⁴,Dechant Esther²⁵,Weigel Thomas²⁵,Ciotti Lori⁶,Keane Robert J⁷,Gleysteen Suzanne²⁸,Mickley Diane⁹,Bredella Miriam A²¹⁰,Tan Can Ozan²¹⁰¹¹,Gupta Rajiv²¹⁰,Misra Madhusmita¹²,Schoenfeld David¹¹²,Klibanski Anne¹²,Miller Karen K¹²

Affiliation:

1. Neuroendocrine Unit Massachusetts General Hospital Boston MA USA

2. Harvard Medical School Boston MA USA

3. Eating Disorders Clinical and Research Program Massachusetts General Hospital Boston MA USA

4. Cambridge Eating Disorder Center Cambridge MA USA

5. Klarman Eating Disorders Center Belmont MA USA

6. The Renfrew Center Boston MA USA

7. Walden Behavioral Care Waltham MA USA

8. Beth Israel Deaconess Medical Center Boston MA USA

9. Wilkins Center for Eating Disorders Greenwich CT USA

10. Department of Radiology Massachusetts General Hospital Boston MA USA

11. Spaulding Rehabilitation Hospital Boston MA USA